What are alpha-GPC’s main benefits?

    Researchedby:
    Last Updated: December 22, 2023

    Oral supplementation of alpha-GPC is primarily of interest for nootropic or cognitive-enhancement purposes. While there are certain cases in which alpha-GPC seems to be beneficial, there isn’t any research in healthy humans that suggests it provides some general “cognitive enhancement”. There are a number of rodent studies that show an improvement in learning and memory in supplemented animals, but these effects have yet to be demonstrated in healthy humans. In older adults with mild to moderate dementia — which involves disrupted cholinergic neurotransmission — alpha-GPC improves cognitive symptoms (e.g., memory and attention impairment).[1][2] Alpha-GPC may also help those with glioblastoma, a type of brain cancer that is very difficult to treat. A 2022 study found that the overall survival rate of people with glioblastoma improved when alpha-GPC was added to surgical and chemotherapeutic treatments.[3] Alpha-GPC may also improve the effectiveness of acetylcholinesterase inhibitors (drugs that increase acetylcholine’s availability by slowing down its breakdown), which are used for treating Alzheimer’s disease.[1][4] When Alpha-GPC is added to this standard Alzheimer’s treatment, it may improve behavioral symptoms, functional outcomes, and cognitive symptoms.[5]

    Athletes are another population that may benefit from alpha-GPC supplementation. Preliminary evidence suggests that alpha-GPC increases vertical jump power. In one study, both caffeine and alpha-GPC improved vertical jump power, with the greatest improvement in participants who took a 200 mg dose of alpha-GPC.[6][7] Additionally, a pilot study reported that alpha-GPC increased peak bench press force, but not peak power or rate of force development.[8] In one study done in trained cyclists, alpha-GPC improved peak power and time to fatigue when used with L-citrulline.[9] Whether alpha-GPC increases isometric strength is currently unclear.[7][10]

    References

    1. ^De Jesus Moreno Moreno MCognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trialClin Ther.(2003 Jan)
    2. ^Enea Traini, Vincenzo Bramanti, Francesco AmentaCholine alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agentCurr Alzheimer Res.(2013 Dec)
    3. ^Kim YJ, Lee TK, Noh MG, Jung TY, Kim IY, Jung S, Lee KH, Moon KSEffect of Choline Alphoscerate on the Survival of Glioblastoma Patients: A Retrospective, Single-Center Study.J Clin Med.(2022-Oct-13)
    4. ^Kansakar U, Trimarco V, Mone P, Varzideh F, Lombardi A, Santulli GCholine supplements: An update.Front Endocrinol (Lausanne).(2023)
    5. ^Sagaro GG, Traini E, Amenta FActivity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.J Alzheimers Dis.(2023)
    6. ^Parker A, Byars A, Purpura M, Jager RThe effects of alpha-glycerylphosphorylcholine, caffeine or placebo on markers of mood, cognitive function, power, speed, and agilityJ Int Soc Sports Nutr.(2015 Sep)
    7. ^Lena Marcus, Jason Soileau, Lawrence W Judge, David BellarEvaluation of the effects of two doses of alpha glycerylphosphorylcholine on physical and psychomotor performanceJ Int Soc Sports Nutr.(2017 Oct 5)
    8. ^Ziegenfuss T, Landis J, Hofheins JAcute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exerciseJ Int Soc Sports Nutr.(2008 Sep)
    9. ^Harrington RNEffects of branched chain amino acids, l-citrulline, and alpha-glycerylphosphorylcholine supplementation on exercise performance in trained cyclists: a randomized crossover trial.J Int Soc Sports Nutr.(2023-Dec)
    10. ^David Bellar, Nina R LeBlanc, Brian CampbellThe effect of 6 days of alpha glycerylphosphorylcholine on isometric strengthJ Int Soc Sports Nutr.(2015 Nov 17)